Enzo Biochem (ENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 07-2023 | 07-2022 | 07-2021 | 07-2020 | 07-2019 | |
| Sales | 31,061 | 32,643 | 117,731 | 76,021 | 81,170 |
| Cost of Goods | 19,495 | 19,213 | 64,154 | 52,251 | 57,922 |
| Gross Profit | 11,566 | 13,430 | 53,577 | 23,770 | 23,248 |
| Operating Expenses | 36,797 | 30,670 | 53,039 | 54,388 | 22,437 |
| Operating Income | -24,736 | -17,027 | 692 | -30,367 | 1,733 |
| Other Income | -286 | -3,312 | 7,183 | 1,847 | 756 |
| Pre-tax Income | -25,022 | -20,339 | 7,875 | -28,520 | 2,489 |
| Net Income Continuous | -25,022 | -20,339 | 7,875 | -28,520 | 2,489 |
| Net Income Discontinuous | 45,310 | 2,078 | N/A | N/A | N/A |
| Net Income | $20,288 | $-18,261 | $7,875 | $-28,520 | $2,489 |
| EPS Basic Total Ops | 0.41 | -0.38 | 0.16 | -0.60 | 0.05 |
| EPS Basic Continuous Ops | -0.51 | -0.42 | 0.16 | -0.60 | 0.05 |
| EPS Basic Discontinuous Ops | 0.92 | 0.04 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.41 | -0.38 | 0.16 | -0.60 | 0.05 |
| EPS Diluted Continuous Ops | -0.51 | -0.42 | 0.16 | -0.60 | 0.05 |
| EPS Diluted Discontinuous Ops | 0.92 | 0.04 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -0.51 | -0.23 | 0.21 | -0.51 | -0.56 |
| EBITDA(a) | $-22,054 | $-14,200 | $3,345 | $-27,587 | $4,769 |